May 10, 2016
NEWTON, Mass., May 10, 2016 Dynasil Corporation of America (NASDAQ: DYSL) today announced that its contract research subsidiary, RMD Inc., has received six grants totaling $3.8 million under the NASA, National Institute of Health and Department of Energy’s funding programs.
“RMD’s world-class research continues to be on the cutting edge of new technologies,” said Peter Sulick, Dynasil’s Chairman of the Board, Chief Executive Officer and President. “Government agencies continue to tap our highly specialized materials research expertise to develop technology for critical medical and scientific research applications.”
These awards focus on the development of advanced radiation detectors for NASA’s space exploration missions, biotechnology for the National Institute of Health, and new radiation detection materials to assist the Department of Energy’s scientific research programs.
“The research projects RMD is undertaking through these programs exemplify some of the world’s most demanding medical and scientific research needs,” said Kanai Shah, Ph.D., President of Dynasil’s RMD subsidiary. “These grants capitalize on our technical and scientific capability in the development of scintillation materials and instrumentation. Dynasil is proud to partner with all of these agencies on these initiatives.”